Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1998 Jul;89(7):733–740. doi: 10.1111/j.1349-7006.1998.tb03278.x

Inhibitory Effects of Ginsenoside Rh2 on Tumor Growth in Nude Mice Bearing Human Ovarian Cancer Cells

Hideyuki Nakata 1, Yoshihiro Kikuchi 1,✉, Takehiko Tode 1, Junko Hirata 1, Tsunekazu Kita 1, Kenji Ishii 1, Kazuya Kudoh 1, Ichiro Nagata 1, Nariyoshi Shinomiya 2
PMCID: PMC5921889  PMID: 9738980

Abstract

Ginsenoside Rh2 (Rh2), isolated from an ethanol extract of the processed root of Panax ginseng CA Meyer, inhibits the growth of B16 melanoma cells. This study was designed to evaluate the ability of Rh2 to inhibit growth of human ovarian cancer cells (HRA) in vitro and in nude mouse. Rh2 inhibited proliferations of various established human ovarian cancer cell lines in a dose‐dependent manner between 10 and 60 μM in vitro and induced apoptosis at around the IC50 dose. When HRA cells were inoculated s.c. into the right flank of nude mice, all mice formed a palpable tumor within 14 days. Although i.p. administration of Rh2 alone hardly inhibited the tumor growth, when Rh2 was combined with cis‐diamminedichloroplatinum(II) (CDDP) the tumor growth was significantly inhibited, compared to treatment with CDDP alone. When mice were treated p.o. with Rh2 daily (but not weekly), the tumor growth was significantly (P<0.01) inhibited, compared to CDDP treatment alone. When Rh2 was combined with CDDP, the degree of tumor growth retardation was not potentiated. The survival time was significantly (P<, we examined whether p.o. administration of Rh2 has a dose‐dependent inhibitory effect on the tumor growth. I.p. and weekly administration of CDDP had more potent antitumor activity in the order of 1 mg/kg, 2 mg/kg and 4 mg/kg, whereas p.o. and daily administration of Rh2 (0.4 to 1.6 mg/kg) not only had antitumor activity comparable to that of 4 mg/kg CDDP, but also resulted in a significant increase of the survival. Doses of Rh2 used in this study did not result in any adverse side‐effects as confirmed by monitoring hematocrit values and body weight, unlike 4 mg/kg CDDP, which had severe side‐effects. It is noteworthy that p.o. but not i.p. treatment with Rh2 resulted in induction of apoptotic cells in the tumor in addition to augmentation of the natural killer activity in spleen cells from tumor‐bearing nude mice. Thus, particularly in view of the toxicity of CDDP, Rh2 alone would seem to warrant further evaluation for treatment of recurrent or refractory ovarian tumor.

Keywords: key words, Ginsenoside Rh2, Human ovarian cancer cell line, Antitumor activity, Apoptosis, Natural killer activity

Full Text

The Full Text of this article is available as a PDF (540.0 KB).

REFERENCES

  • 1. ) Odashima , S. , Nakayabu , Y. , Honjo , N. and Arichi , S.Induction of phenotypic reverse transformation by ginsenoside in cultured Morris hepatoma cells . Eur. J. Cancer , 15 , 885 – 892 ( 1979. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Odashima , S. , Ohta , T. , Kohno , H. , Matsuda , T. , Kitagawa , I. , Abe , H. and Arichi , S.Control of phenotypic expression of cultured B16 melanoma cells by plant glycosides . Cancer Res. , 45 , 2781 – 2784 ( 1985. ). [PubMed] [Google Scholar]
  • 3. ) Kikuchi , Y. , Sasa , H. , Kita , T. , Hirata , J. , Tode , T. and Nagata , I.Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo . Anti-Cancer Drugs , 2 , 63 – 67 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Tode , T. , Kikuchi , Y. , Kita , T. , Hirata , J. , Imaizumi , E. and Nagata , I.Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice . J. Cancer Res. Clin. Oncol. , 120 , 24 – 26 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Yun , Y.S. , Jo , S. K. , Moon , H. S. , Kim , Y. J. , Oh , Y. R. and Yun , T. K.Effects of red ginseng on natural killer cell activity in mice with lung adenoma induced by urethan and benzo(a)pyrene . Cancer Detect. Prevent. , 1 , ( Suppl. ), 301 – 309 ( 1987. ). [PubMed] [Google Scholar]
  • 6. ) Tode , T. , Kikuchi , Y. , Hirata , J. , Kita , T. and Nagata , I.Effects of red ginseng on the neuroimmunoendocrine functions in patients after surgery of ovarian carcinoma or with perimenopausal complaints . Ginseng Rev. , 22 , 110 – 114 ( 1996. ) ( in Japanese ). [Google Scholar]
  • 7. ) Kikuchi , Y. , Kizawa , I. , Oomori , K. , Miyauchi , M. , Kita , T. , Sugita , M. , Tenjin , Y. and Kato , K.Establishment of a human ovarian cancer cell line capable of forming ascites in nude mice and effects of tranexamic acid on cell proliferation and ascites formation . Cancer Res. , 47 , 592 – 596 ( 1987. ). [PubMed] [Google Scholar]
  • 8. ) Kikuchi , Y. , Hirata , J. , Kita , T. , Imaizumi , E. , Tode , T. and Nagata , I.Enhancement of antineoplastic effect of cis‐diamminedichloroplatinum(II) by clomiphene and tamoxifen in human ovarian cancer cells . Gynecol. Oncol. , 49 , 365 – 372 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Kikuchi , Y. , Iwano , I. and Kato , K.Effect of calmodulin antagonists on human ovarian cancer cell proliferation in vitro. Biochem . Biophys. Res. Commun. , 123 , 385 – 392 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Kikuchi , Y. , Miyauchi , M. , Kizawa , I. , Oomori , K. and Kato , K.Establishment of a cisplatin‐resistant human ovarian cancer cell line . J. Natl. Cancer Inst. , 77 , 1181 – 1185 ( 1986. ). [PubMed] [Google Scholar]
  • 11. ) Saotome , K. , Morita , H. and Umeda , M.Cytotoxicity test with simplified crystal violet staining method using microtitre plates and its application to injection drugs . Toxicol. in Vitro , 3 , 317 – 321 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Vindeløv , L. L. , Christensen , I. J. and Nissen , N. I.A dependent‐trypsin method for the preparation of nuclei for flow cytometric DNA analysis . Cytometry , 3 , 323 – 327 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Oohashi , M. , Sugikawa , E. and Nakanishi , N.Inhibition of p53 protein phosphorylation by 9‐hydroxyellipticine: a possible anticancer mechanism . Jpn. J. Cancer Res. , 86 , 819 – 827 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. ) Gavrieli , Y. , Sherman , Y. and Ben‐Sasson , S. A.Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation . J. Cell Biol. , 119 , 493 – 501 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. ) Fujikawa‐Yamamoto , K. , Ota , T. , Odashima , S. , Abe , H. and Arichi , S.Different response in the cell cycle of tumour cells to ginsenoside Rh2 . Cancer J. , 1 , 349 – 352 ( 1987. ). [Google Scholar]
  • 16. ) Ota , T. , Fujikawa‐Yamamoto , K. , Zong , Z. , Yamazaki , M. , Odashima , S. , Kitagawa , I. , Abe , H. and Arichi , S.Plant‐glycoside modulation of cell surface related to control of differentiation in cultured B16 melanoma cells . Cancer Res. , 47 , 3863 – 3867 ( 1987. ). [PubMed] [Google Scholar]
  • 17. ) Eastman , A.Apoptosis: a product of programmed and unprogrammed cell death . Toxicol. Appl. Pharmacol. , 121 , 160 – 164 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Tode , T. , Kikuchi , Y. , Hirata , J. , Kita , T. , Ishii , K. , Hiramatsu , H. and Nagata , I.Enhancement of natural killer activity by Korean red ginseng and its ingredients in nude mice bearing human ovarian carcinoma . Ginseng Rev. , 20 , 36 – 40 ( 1995. ) ( in Japanese ). [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES